Latanoprost/Timolol (Fixapost®). HTA ID: 21053

Assessment Status Rapid Review Complete
HTA ID 21053
Drug Latanoprost/Timolol
Brand Fixapost®
Indication In adults (including the elderly) for the reduction of intraocular pressure in patients with open angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta‐blockers or prostaglandin analogues.
Assessment Process
Rapid review commissioned 16/11/2021
Rapid review completed 06/12/2021
Rapid review outcome A full HTA is not recommended. The NCPE recommends that Fixapost® not be considered for reimbursement at the submitted price*.

*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.

The HSE has approved reimbursement April 2022.